- call +1-201-465-4211
- email sales@mrinsights.biz
General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management.
Scope of the Report:
General Anesthesia Drugs can be divided into two categories, Intravenous Anesthetics, accounting for 69.62% and Inhalational Anesthetics, accounting for 30.38%. Intravenous Anesthetics widely used drugs are: Propofol, Etomidate, Midazolam, Barbiturates (such as thiopental), and so on. Desflurane, Isoflurane and Sevoflurane are the most widely used Inhalational Anesthetics. Propofol hold the largest market share of General Anesthesia Drugs with 33.83% market share. Sevoflurane market share is over 21.17%, being the second largest market share of General Anesthesia Drugs.
Europe is the largest supplier and consumption market of General Anesthesia Drugs, with a production market share of nearly 38% and sales market share nearly 32%. The second place is USA, following Europe with the production market share of 20% and the sales market share over 28%. Asia is another important market of General Anesthesia Drugs, enjoying 24% production market share and 25% sales market share.
The worldwide market for General Anesthesia Drugs is expected to grow at a CAGR of roughly 3.9% over the next five years, will reach 8170 million US$ in 2024, from 6500 million US$ in 2019, according to a new study.
This report focuses on the General Anesthesia Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Astrazeneca
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Mylan
Nhwa
Hengrui
Lunan
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Propofol
Etomidate
Midazolam
Sevoflurane
Isoflurane
Others
Market Segment by Applications, can be divided into
Intravenous Anesthetics
Inhalational Anesthetics
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe General Anesthesia Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of General Anesthesia Drugs, with price, sales, revenue and global market share of General Anesthesia Drugs in 2017 and 2018.
Chapter 3, the General Anesthesia Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the General Anesthesia Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, General Anesthesia Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe General Anesthesia Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 General Anesthesia Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Propofol
1.2.2 Etomidate
1.2.3 Midazolam
1.2.4 Sevoflurane
1.2.5 Isoflurane
1.2.6 Others
1.3 Market Analysis by Applications
1.3.1 Intravenous Anesthetics
1.3.2 Inhalational Anesthetics
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Astrazeneca
2.1.1 Business Overview
2.1.2 General Anesthesia Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Astrazeneca General Anesthesia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Fresenius-Kabi
2.2.1 Business Overview
2.2.2 General Anesthesia Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Fresenius-Kabi General Anesthesia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 AbbVie
2.3.1 Business Overview
2.3.2 General Anesthesia Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AbbVie General Anesthesia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Baxter Healthcare
2.4.1 Business Overview
2.4.2 General Anesthesia Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Baxter Healthcare General Anesthesia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 B.Braun
2.5.1 Business Overview
2.5.2 General Anesthesia Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 B.Braun General Anesthesia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Maruishi
2.6.1 Business Overview
2.6.2 General Anesthesia Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Maruishi General Anesthesia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Piramal
2.7.1 Business Overview
2.7.2 General Anesthesia Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Piramal General Anesthesia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Hikma Pharmaceuticals
2.8.1 Business Overview
2.8.2 General Anesthesia Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Hikma Pharmaceuticals General Anesthesia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Mylan
2.9.1 Business Overview
2.9.2 General Anesthesia Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Mylan General Anesthesia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Nhwa
2.10.1 Business Overview
2.10.2 General Anesthesia Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Nhwa General Anesthesia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Hengrui
2.11.1 Business Overview
2.11.2 General Anesthesia Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Hengrui General Anesthesia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Lunan
2.12.1 Business Overview
2.12.2 General Anesthesia Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Lunan General Anesthesia Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global General Anesthesia Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global General Anesthesia Drugs Sales and Market Share by Manufacturer (2017-2018)
3.2 Global General Anesthesia Drugs Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 General Anesthesia Drugs Manufacturer Market Share in 2018
3.3.2 Top 6 General Anesthesia Drugs Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global General Anesthesia Drugs Market Analysis by Regions
4.1 Global General Anesthesia Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global General Anesthesia Drugs Sales and Market Share by Regions (2014-2019)
4.1.2 Global General Anesthesia Drugs Revenue and Market Share by Regions (2014-2019)
4.2 North America General Anesthesia Drugs Sales and Growth Rate (2014-2019)
4.3 Europe General Anesthesia Drugs Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific General Anesthesia Drugs Sales and Growth Rate (2014-2019)
4.5 South America General Anesthesia Drugs Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa General Anesthesia Drugs Sales and Growth Rate (2014-2019)
5 North America General Anesthesia Drugs by Country
5.1 North America General Anesthesia Drugs Sales, Revenue and Market Share by Country
5.1.1 North America General Anesthesia Drugs Sales and Market Share by Country (2014-2019)
5.1.2 North America General Anesthesia Drugs Revenue and Market Share by Country (2014-2019)
5.2 United States General Anesthesia Drugs Sales and Growth Rate (2014-2019)
5.3 Canada General Anesthesia Drugs Sales and Growth Rate (2014-2019)
5.4 Mexico General Anesthesia Drugs Sales and Growth Rate (2014-2019)
6 Europe General Anesthesia Drugs by Country
6.1 Europe General Anesthesia Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe General Anesthesia Drugs Sales and Market Share by Country (2014-2019)
6.1.2 Europe General Anesthesia Drugs Revenue and Market Share by Country (2014-2019)
6.2 Germany General Anesthesia Drugs Sales and Growth Rate (2014-2019)
6.3 UK General Anesthesia Drugs Sales and Growth Rate (2014-2019)
6.4 France General Anesthesia Drugs Sales and Growth Rate (2014-2019)
6.5 Russia General Anesthesia Drugs Sales and Growth Rate (2014-2019)
6.6 Italy General Anesthesia Drugs Sales and Growth Rate (2014-2019)
7 Asia-Pacific General Anesthesia Drugs by Country
7.1 Asia-Pacific General Anesthesia Drugs Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific General Anesthesia Drugs Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific General Anesthesia Drugs Revenue and Market Share by Country (2014-2019)
7.2 China General Anesthesia Drugs Sales and Growth Rate (2014-2019)
7.3 Japan General Anesthesia Drugs Sales and Growth Rate (2014-2019)
7.4 Korea General Anesthesia Drugs Sales and Growth Rate (2014-2019)
7.5 India General Anesthesia Drugs Sales and Growth Rate (2014-2019)
7.6 Southeast Asia General Anesthesia Drugs Sales and Growth Rate (2014-2019)
8 South America General Anesthesia Drugs by Country
8.1 South America General Anesthesia Drugs Sales, Revenue and Market Share by Country
8.1.1 South America General Anesthesia Drugs Sales and Market Share by Country (2014-2019)
8.1.2 South America General Anesthesia Drugs Revenue and Market Share by Country (2014-2019)
8.2 Brazil General Anesthesia Drugs Sales and Growth Rate (2014-2019)
8.3 Argentina General Anesthesia Drugs Sales and Growth Rate (2014-2019)
8.4 Colombia General Anesthesia Drugs Sales and Growth Rate (2014-2019)
9 Middle East and Africa General Anesthesia Drugs by Countries
9.1 Middle East and Africa General Anesthesia Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa General Anesthesia Drugs Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa General Anesthesia Drugs Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia General Anesthesia Drugs Sales and Growth Rate (2014-2019)
9.3 Turkey General Anesthesia Drugs Sales and Growth Rate (2014-2019)
9.4 Egypt General Anesthesia Drugs Sales and Growth Rate (2014-2019)
9.5 Nigeria General Anesthesia Drugs Sales and Growth Rate (2014-2019)
9.6 South Africa General Anesthesia Drugs Sales and Growth Rate (2014-2019)
10 Global General Anesthesia Drugs Market Segment by Type
10.1 Global General Anesthesia Drugs Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global General Anesthesia Drugs Sales and Market Share by Type (2014-2019)
10.1.2 Global General Anesthesia Drugs Revenue and Market Share by Type (2014-2019)
10.2 Propofol Sales Growth and Price
10.2.1 Global Propofol Sales Growth (2014-2019)
10.2.2 Global Propofol Price (2014-2019)
10.3 Etomidate Sales Growth and Price
10.3.1 Global Etomidate Sales Growth (2014-2019)
10.3.2 Global Etomidate Price (2014-2019)
10.4 Midazolam Sales Growth and Price
10.4.1 Global Midazolam Sales Growth (2014-2019)
10.4.2 Global Midazolam Price (2014-2019)
10.5 Sevoflurane Sales Growth and Price
10.5.1 Global Sevoflurane Sales Growth (2014-2019)
10.5.2 Global Sevoflurane Price (2014-2019)
10.6 Isoflurane Sales Growth and Price
10.6.1 Global Isoflurane Sales Growth (2014-2019)
10.6.2 Global Isoflurane Price (2014-2019)
10.7 Others Sales Growth and Price
10.7.1 Global Others Sales Growth (2014-2019)
10.7.2 Global Others Price (2014-2019)
11 Global General Anesthesia Drugs Market Segment by Application
11.1 Global General Anesthesia Drugs Sales Market Share by Application (2014-2019)
11.2 Intravenous Anesthetics Sales Growth (2014-2019)
11.3 Inhalational Anesthetics Sales Growth (2014-2019)
12 General Anesthesia Drugs Market Forecast (2019-2024)
12.1 Global General Anesthesia Drugs Sales, Revenue and Growth Rate (2019-2024)
12.2 General Anesthesia Drugs Market Forecast by Regions (2019-2024)
12.2.1 North America General Anesthesia Drugs Market Forecast (2019-2024)
12.2.2 Europe General Anesthesia Drugs Market Forecast (2019-2024)
12.2.3 Asia-Pacific General Anesthesia Drugs Market Forecast (2019-2024)
12.2.4 South America General Anesthesia Drugs Market Forecast (2019-2024)
12.2.5 Middle East and Africa General Anesthesia Drugs Market Forecast (2019-2024)
12.3 General Anesthesia Drugs Market Forecast by Type (2019-2024)
12.3.1 Global General Anesthesia Drugs Sales Forecast by Type (2019-2024)
12.3.2 Global General Anesthesia Drugs Market Share Forecast by Type (2019-2024)
12.4 General Anesthesia Drugs Market Forecast by Application (2019-2024)
12.4.1 Global General Anesthesia Drugs Sales Forecast by Application (2019-2024)
12.4.2 Global General Anesthesia Drugs Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure General Anesthesia Drugs Picture
Table Product Specifications of General Anesthesia Drugs
Figure Global Sales Market Share of General Anesthesia Drugs by Types in 20
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
